0000000000703535

AUTHOR

Stephane Larre

showing 3 related works from this author

THE IMPACT OF RE-TUR ON CLINICAL OUTCOMES IN A LARGE COHORT OF T1G3 PATIENTS TREATED WITH BCG.

2014

bladder cancer BCGSettore MED/24 - Urologia
researchProduct

RECURRENCE AND PROGRESSION ACCORDING TO STAGE AT RE-TUR IN T1G3 BLADDER CANCER PATIENTS TREATED WITH BCG: NOT AS BAD AS PREVIOUSLY THOUGHT

2017

Bladder cancer BCG T1HG re-TURSettore MED/24 - Urologia
researchProduct

RISK FACTORS FOR RESIDUAL DISEASE AT RE-TUR IN T1G3 BLADDER CANCER

2017

Bladder cancer T1HG re-TUR BCGSettore MED/24 - Urologia
researchProduct